Loading clinical trials...
Loading clinical trials...
Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens
The purpose of this study is to validate the performance characteristics of an assay that tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration submission.
Age
17 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Taipei Blood Center Taiwan Blood Service Foundation (TBSF)
Taipei, Taiwan
Start Date
August 8, 2007
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
February 21, 2021
10,290
ACTUAL participants
Blood test
DEVICE
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions